Morpholine → rac4-(5-Methanesulfonyl-2-morpholin4-yl-benzoyl)-3-methyl-piperazine-1-carboxylic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14](=[O:26])[C:15]2[CH:20]=[C:19]([S:21]([CH3:24])(=[O:23])=[O:22])[CH:18]=[CH:17][C:16]=2I)[CH:10]([CH3:27])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[NH:28]1[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1>>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][N:11]([C:14](=[O:26])[C:15]2[CH:20]=[C:19]([S:21]([CH3:24])(=[O:23])=[O:22])[CH:18]=[CH:17][C:16]=2[N:28]2[CH2:33][CH2:32][O:31][CH2:30][CH2:29]2)[CH:10]([CH3:27])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]Participants
3
Conditions
- Temperature
- 100 °C
Procedure
rac-4-(2-Iodo-5-methanesulfonyl-benzoyl)-3-methyl-piperazine-1-carboxylic acid tert-butyl ester (400 mg, 0.78 mmol) was poured into morpholine (5.0 ml) and the reaction mixture was stirred for 15 h at 100° C. before being concentrated in vacuo. The residue was then purified by column chromatography (SiO2, 20 g, dichloromethane/methanol=0-5%) to give the title compound as a colorless foam (322 mg, 88%). MS (m/e): 468.3 (M+H+).
Workup
- concentrationbefore being concentrated in vacuo
- customThe residue was then purified by column chromatography (SiO2, 20 g, dichloromethane/methanol=0-5%)
Sources & evidence
- ORD record
- ord-2810facb3ac342688269db6ab5e3bf85
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07595314B2
Reaction notes
Loading…